Skip to main content
. 2022 Apr 27;23(9):4808. doi: 10.3390/ijms23094808

Figure 2.

Figure 2

Scheme demonstrating the role of lipid mediators in the development of inflammation in atherosclerosis. The development and progression of atherosclerosis are associated with an imbalance between inflammation and inflammation resolution. Lipid mediators derived from PUFAs are involved in these processes.